다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
The breast journal, v.24 no.4, 2018년, pp.541 - 548
Yadav, Siddhartha (Hematology‐) , Jinna, Sruthi (Oncology Fellowship Program, Mayo Clinic, Rochester, MN, USA) , Pereira‐Rodrigues, Otavio (Department of Internal Medicine, Beaumont Health, Royal Oak, MI, USA) , Reeves, Ashley (Department of Internal Medicine, Beaumont Health, Royal Oak, MI, USA) , Campian, Sarah (Nancy and James Grosfeld Cancer Genetics Center, Beaumont Cancer Institute, Beaumont Health, Royal Oak, MI, USA) , Sufka, Amy (Nancy and James Grosfeld Cancer Genetics Center, Beaumont Cancer Institute, Beaumont Health, Royal Oak, MI, USA) , Zakalik, Dana (Nancy and James Grosfeld Cancer Genetics Center, Beaumont Cancer Institute, Beaumont Health, Royal Oak, MI, USA)
AI-Helper
AbstractThe utility and benefit of integrating germ‐line genetic testing into the management of newly diagnosed breast cancer is not fully understood. This study evaluates the impact of preoperative genetic testing on surgical decision making in patients with newly diagnosed breast cancer. Wom...
Siegel Cancer statistics, 2016 CA Cancer J Clin 2016 10.3322/caac.21332 66 7
Foulkes Inherited susceptibility to common cancers N Engl J Med 2008 10.1056/NEJMra0802968 359 2143
Chen Meta-analysis of BRCA1 and BRCA2 penetrance J Clin Oncol 2007 10.1200/JCO.2006.09.1066 25 1329
Ponder Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases Br J Cancer 2000 10.1054/bjoc.2000.1407 83 1301
Antoniou Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 2003 10.1086/375033 72 1117
Ford Risks of cancer in BRCA1-mutation carriers. breast cancer linkage consortium Lancet 1994 10.1016/S0140-6736(94)91578-4 343 692
Risch Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada J Natl Cancer Inst 2006 10.1093/jnci/djj465 98 1694
Mavaddat Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE J Natl Cancer Inst 2013 10.1093/jnci/djt095 105 812
Broek Impact of age at primary breast cancer on contralateral breast cancer risk in BRCA1/2 mutation carriers J Clin Oncol 2016 10.1200/JCO.2015.62.3942 34 409
Sprundel Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers Br J Cancer 2005 10.1038/sj.bjc.6602703 93 287
Metcalfe Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis BMJ 2014 10.1136/bmj.g226 348 g226
Giuliano Society of surgical oncology: position statement on prophylactic mastectomy. approved by the society of surgical oncology executive council, march 2007 Ann Surg Oncol 2007 10.1245/s10434-007-9447-z 14 2425
Balmana BRCA in breast cancer: ESMO clinical practice guidelines Ann Oncol 2011 10.1093/annonc/mdr373 22 Suppl 6 vi31
Gradishar Invasive breast cancer version 1.2016, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw 2016 10.6004/jnccn.2016.0037 14 324
Yi Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy Cancer Prev Res (Phila) 2010 10.1158/1940-6207.CAPR-09-0130 3 1026
Evans Surgical decisions made by 158 women with hereditary breast cancer aged <50 years Eur J Surg Oncol 2005 10.1016/j.ejso.2005.05.007 31 1112
Trainer The role of BRCA mutation testing in determining breast cancer therapy Nat Rev Clin Oncol 2010 10.1038/nrclinonc.2010.175 7 708
Schwartz Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients J Clin Oncol 2004 10.1200/JCO.2004.04.086 22 1823
Weitzel Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis Arch Surg 2003 10.1001/archsurg.138.12.1323 138 1323
Cellini Multiple re-excisions versus mastectomy in patients with persistent residual disease following breast conservation surgery Am J Surg 2005 10.1016/j.amjsurg.2005.03.005 189 662
Coopey The safety of multiple re-excisions after lumpectomy for breast cancer Ann Surg Oncol 2011 10.1245/s10434-011-1802-4 18 3797
Lokich Preoperative genetic testing affects surgical decision making in breast cancer patients Gynecol Oncol 2014 10.1016/j.ygyno.2014.05.028 134 326
Flippo-Morton Surgical decision making in the BRCA-positive population: institutional experience and comparison with recent literature Breast J 2016 10.1111/tbj.12521 22 35
Schwartz Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients Cancer Epidemiol Biomarkers Prev 2005 10.1158/1055-9965.EPI-03-0545 14 1003
Stolier Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation Breast J 2004 10.1111/j.1075-122X.2004.21543.x 10 475
Stolier Newly diagnosed breast cancer patients choose bilateral mastectomy over breast-conserving surgery when testing positive for a BRCA1/2 mutation Am Surg 2005 10.1177/000313480507101209 71 1031
Reavey Update on breast reconstruction in breast cancer Curr Opin Obstet Gynecol 2008 10.1097/GCO.0b013e3282f2329b 20 61
Palomares Genetic cancer risk assessment in the newly diagnosed breast cancer patient is useful and possible in practice J Clin Oncol 2005 10.1200/JCO.2005.05.157 23 3165
Francken Breast cancer in women at high risk: the role of rapid genetic testing for BRCA1 and -2 mutations and the consequences for treatment strategies Breast 2013 10.1016/j.breast.2013.07.045 22 561
10.1158/1538-7445.SABCS14-P4-12-13 Yadav S Pereira-Rodrigues O Dohany L Dreyfuss H Experience of pre-operative genetic testing on surgical decision making in newly diagnosed breast cancer patients (abstract) Cancer Res 2015 75
Wevers Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial Br J Cancer 2014 10.1038/bjc.2013.805 110 1081
Cortesi A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive italian women Ann Oncol 2014 10.1093/annonc/mdt422 25 57
Bleicher Preoperative delays in the US medicare population with breast cancer J Clin Oncol 2012 10.1200/JCO.2012.41.7972 30 4485
Bleicher Time to surgery and breast cancer survival in the united states JAMA Oncol 2016 10.1001/jamaoncol.2015.4508 2 330
Tuttle Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment J Clin Oncol 2007 10.1200/JCO.2007.12.3141 25 5203
Habermann Are mastectomy rates really increasing in the united states? J Clin Oncol 2010 10.1200/JCO.2009.27.6774 28 3437
McAlister Surgical decisions of newly diagnosed breast cancer patients following genetic referral J Clin Oncol 2015 10.1200/jco.2015.33.28_suppl.40 33 28_Suppl 40
Jones Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution Ann Surg Oncol 2009 10.1245/s10434-009-0547-9 16 2691
Sorbero Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy Ann Surg Oncol 2009 10.1245/s10434-009-0362-3 16 1597
Arrington Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer Ann Surg Oncol 2009 10.1245/s10434-009-0641-z 16 2697
Swisher Usefulness of multigene testing: catching the train that's left the station JAMA Oncol 2015 10.1001/jamaoncol.2015.2699 1 951
Robson American society of clinical oncology policy statement update: genetic and genomic testing for cancer susceptibility J Clin Oncol 2015 10.1200/JCO.2015.63.0996 33 3660
Hall Gene panel testing for inherited cancer risk J Natl Compr Canc Netw 2014 10.6004/jnccn.2014.0128 12 1339
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.